JEREMY FRIX: Open Payments
NPI 1164450862 · MERIDIAN, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,158 in 154 payments from 29 companies in 2025. Trend: 2023 $3,241 · 2024 $2,822 · 2025 $3,158
Food & beverage: $3,158
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 28 | $1,024 |
| PFIZER INC. | 25 | $385 |
| AstraZeneca Pharmaceuticals LP | 6 | $267 |
| Novo Nordisk Inc | 15 | $209 |
| ABBVIE INC. | 19 | $168 |
| GlaxoSmithKline, LLC. | 12 | $145 |
| Phathom Pharmaceuticals, Inc. | 7 | $130 |
| Novartis Pharmaceuticals Corporation | 4 | $89 |
| Xeris Pharmaceuticals, Inc. | 4 | $84 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $78 |
Products named: REPATHA, FARXIGA, NURTEC ODT, ELIQUIS, VOQUEZNA, OTEZLA, TRELEGY ELLIPTA, RECORLEV.
Industry payments across ID — which companies pay providers there.
